Adjunctive brivaracetam for uncontrolled focal and generalized epilepsies: Results of a phase III, double-blind, randomized, placebo-controlled, flexible-dose trial

Efficacy and tolerability of adjunctive brivaracetam in adults with uncontrolled partial-onset seizures: A phase IIb, randomized, controlled trial

(2012) Wim Van Paesschen et al.   EPILEPSIA

Comparative safety of antiepileptic drugs during pregnancy

(2012) S. Hernandez-Diaz et al.   NEUROLOGY

Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: Open-label, noncomparative, multicenter, long-term follow-up study

(2011) Norman Delanty et al.   EPILEPSIA

Teratogenicity of the newer antiepileptic drugs – the Australian experience

(2011) F.J.E. Vajda et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Child development following in utero exposure: Levetiracetam vs sodium valproate

(2011) R. Shallcross et al.   NEUROLOGY

Adjunctive brivaracetam for refractory partial-onset seizures: A randomized, controlled trial

(2010) J. A. French et al.   NEUROLOGY

Minimizing AED Adverse Effects: Improving Quality of Life in the Interictal State in Epilepsy Care

(2009) Erik St. Louis   Current Neuropharmacology

Some treatments cause seizure aggravation in idiopathic epilepsies (especially absence epilepsy)

(2009) Ernest R. Somerville   EPILEPSIA

Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A

(2008) A Matagne et al.   BRITISH JOURNAL OF PHARMACOLOGY

Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures

(2008) S. Noachtar et al.   NEUROLOGY